Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer].

Aurello P, Rossi S, D'Angelo F, Nigri G, Cicchini C, Ciardi A, Coluccia P, Ercolani G, Cescon M, Cucchetti A, Ravaioli M, Del Gaudio M, Ramacciato G.

Chir Ital. 2007 Jul-Aug;59(4):435-44. Italian.

PMID:
17966762
2.

Correlation between spontaneous apoptosis and the expression of angiogenic factors in advanced gastric adenocarcinoma.

Ikeguchi M, Cai J, Fukuda K, Oka S, Katano K, Tsujitani S, Maeta M, Kaibara N.

J Exp Clin Cancer Res. 2001 Jun;20(2):257-63.

PMID:
11484984
3.

Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer.

Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Ehi K, Arima H, Mataki Y, Nakajo A, Ishigami S, Aikou T.

J Surg Oncol. 2009 Mar 1;99(3):148-53. doi: 10.1002/jso.21228.

PMID:
19117016
4.

Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.

Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T, Sugihara K.

Ann Surg Oncol. 2007 Oct;14(10):2738-47. Epub 2007 Aug 9.

PMID:
17687613
5.

Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue.

Tatsuguchi A, Matsui K, Shinji Y, Gudis K, Tsukui T, Kishida T, Fukuda Y, Sugisaki Y, Tokunaga A, Tajiri T, Sakamoto C.

Hum Pathol. 2004 Apr;35(4):488-95.

PMID:
15116331
6.

[New markers for pharmacological targeting in bladder cancer with lymph node metastasis].

Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C.

Aktuelle Urol. 2007 Sep;38(5):392-7. German.

PMID:
17907066
7.

Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.

Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Ohro S, Tatebe S, Tsujitani S, Ikeguchi M.

J Surg Oncol. 2007 Feb 1;95(2):123-8.

PMID:
17262742
9.

Vascular endothelial growth factor C and microvessel density in gastric carcinoma: correlation with clinicopathological factors. Our experience and review of the literature.

Aurello P, Rossi Del Monte S, D'Angelo F, Cicchini C, Ciardi A, Bellagamba R, Ravaioli M, Ramacciato G.

Oncol Res. 2009;17(9):405-11.

PMID:
19718947
10.

Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.

Tsutsumi S, Kuwano H, Shimura T, Morinaga N, Mochiki E, Asao T.

Hepatogastroenterology. 2005 Mar-Apr;52(62):629-32.

PMID:
15816493
11.

Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.

Tang H, Wang J, Bai F, Zhai H, Gao J, Hong L, Xie H, Zhang F, Lan M, Yao W, Liu J, Wu K, Fan D.

Cancer Invest. 2008 Feb;26(1):60-7. doi: 10.1080/07357900701519279.

PMID:
18181047
12.

Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.

Oh SY, Kwon HC, Kim SH, Jang JS, Kim MC, Kim KH, Han JY, Kim CO, Kim SJ, Jeong JS, Kim HJ.

BMC Cancer. 2008 May 1;8:123. doi: 10.1186/1471-2407-8-123.

13.

Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.

Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, Ozmen V, Gulluoglu M, Kapran Y.

Hepatogastroenterology. 2009 May-Jun;56(91-92):908-13.

PMID:
19621727
14.

Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.

Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M, Kuscu E.

Pathol Res Pract. 2008;204(6):379-87. doi: 10.1016/j.prp.2008.01.011. Epub 2008 Mar 17.

PMID:
18343598
15.

Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.

Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, Lin WC, Lai PL, Hu RH, Yuan RH.

Ann Surg Oncol. 2007 Oct;14(10):2748-58. Epub 2007 Aug 7.

PMID:
17680316
16.

Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients.

Gretschel S, Astrosini Ch, Vieth M, Jöns T, Tomov T, Höcker M, Schlag PM, Kemmner W.

Eur J Surg Oncol. 2008 Jun;34(6):642-7. Epub 2007 Nov 26.

PMID:
18023552
17.

Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.

Lieto E, Ferraraccio F, Orditura M, Castellano P, Mura AL, Pinto M, Zamboli A, De Vita F, Galizia G.

Ann Surg Oncol. 2008 Jan;15(1):69-79. Epub 2007 Sep 26.

PMID:
17896140
18.

The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma.

Han FH, Li HM, Zheng DH, He YL, Zhan WH.

Eur J Surg Oncol. 2010 Dec;36(12):1172-9. doi: 10.1016/j.ejso.2010.09.002.

PMID:
20888167
19.
20.

Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.

Kamei S, Kono K, Amemiya H, Takahashi A, Sugai H, Ichihara F, Fujii H, Matsumoto Y.

J Gastroenterol. 2003;38(6):540-7.

PMID:
12825129

Supplemental Content

Support Center